NANCY ARNOLD: Open Payments
NPI 1730156258 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 21 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $644 · 2025 $468
Food & beverage: $374Education: $94
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $113 |
| Evofem Biosciences, Inc. | 5 | $84 |
| Amgen Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| MILLICENT US INC | 2 | $34 |
| ABBVIE INC. | 1 | $34 |
| Exeltis, USA Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $21 |
Products named: Phexxi, EVENITY, FEMLYV, UBRELVY, SLYND, ZEPBOUND, Tymlos, Wegovy.
Industry payments across MO — which companies pay providers there.
